Abstract
In the past 10 years clinical trials have confirmed the value of breast conserving therapy for invasive breast cancer and many authorities now consider this the preferred and appropriate treatment (NCI Consensus Statement 1992a). However controversy still surrounds the treatment of ductal carcinoma in situ (DCIS). This uncertainty relates in part to a deficiency of prospective studies; such studies have begun only recently and many are not yet concluded. The controversy also relates to the perception that DCIS may be cured by breast ablation, whereas recurrence in a more aggressive form may occur with breast conserving surgery and the patient may develop invasive breast cancer with metastases resulting in death. The real question therefore is how often does this last scenario take place? Also, the expectation mastectomy is 100% curative needs to be critically examined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arnesson LG, Smeds S, Fagerberg G, Grontoft O (1989) Follow-up of two treatment modlalities for ductal cancer in situ of the breast. Br J Surg 76: 672–675
Bornstein BA, Recht A, Connolly JL, Schnitt SJ et al. (1991) Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 67: 7–13
Bradley SJ, Weaver DW, Bouwman DL (1990) Alternatives in the surgical management of in situ breast cancer. A meta-analysis of outcome. Am Surg 56: 428–432
Carpenter R, Boulter PS, Cooke T, Gibbs NM (1989) Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 76: 564–567
Fisher ER, Sass R, Fisher B et al. (1986) Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol B-06). I. Intraductal carcinoma ( DCIS ). Cancer 57: 197–208
Fisher B, Constantino J, Redmond C, Fisher E, Margolese R, Dimitrov Nikolay et al. (1993) Lumpectomy compared with lumpectomy and radiationn therapy for the treatment of intraductal breast cancer. N Engl J Med 328: 22: 1581 –1586
Holland R, Veling SH, Mravunac M et al. (1985) Histologic multifocality of Tis, TI-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 56: 979–990
Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JHCI et al. (1990) The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8 (1): 113–118
Kurtz JM, Jacquemier J, Torhorst J, Spitalier J-M, Amalric R, Hunig R et al. (1989) Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63: 1630–1635
Kuske RR, Bean JM, Garcia DM, Perez CA, Andriole D, Philpott G, Fineberg B (1993) Breast conservation therapy for intraductal carcinoma of the breast. J Radiat Oncol Biol Phys 26: 391–396
Lagios MD (1990) Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am 70 (4): 853–871
Lagios MD, Westdahl PH, Margolin FR, Rose MR (1982) Duct carcinoma in situ: relationship of non invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short-term treatment failures. Cancer 50: 1309–1314
NCI Consensus Statement (1992a) Treatment of early-stage breast cancer. Monogr Natl Cancer Inst 11: 1–5
Margolese R (1992b) Surgical considerations in selecting local therapy. Monogr Natl Cancer Inst 11: 41–48
Posner MC, Wolmark N (1992) Non-invasive breast carcinoma. Breast Cancer Res Treat 21: 155–164
Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, Come S, Henderson IC, Slavin S, Harris JR (1985) Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16: 3–9
Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris J (1994) The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 72: 1746–1751
Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS (1992) Subclinical ductal carcinoma in situ of the breast. Cancer 70: 2468–2474
Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Garnagami P, Hoffman RS, Fingerhut AG, Lewinsky BS, Colburn W, Handel N (1987) Axillary lymph node dissection for intraductal breast cancer—Is it indicated? Cancer 59: 1819–1824
Silverstein MJ, Cohlan BF, Gierson ED, Furmanski M, Gamagami P et al. (1992) Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 28 (2/3): 630–634
Sohn LJ, Yeh IT, Kurtz J, Fourguet A, Recht A, Kuske R et al. (1993) Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation. Cancer 71: 8: 2532–2542
Stotter AT, McNeese M, Oswald MJ, Ames FC, Romsdahl MM (1990) The role of limited surgery with irradiationn in primary treatment of ductal in situ breast cancer. Radiat Oncal Biol Phys 18: 283–287
Temple WJ, Jenkins M, Alexander F, Hwang WS, Marx LH et al. (1989) Natural history of in situ breast cancer in a defined population. Ann Surg 210 (5): 653–657
Zafrani B, Fourquet A, Vilco JR, Legal M, Calle R (1986) Conservative management of intraducatal breast carcinoma with tumorectomy and radiation therapy. Cancer 57: 1299–1301
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Margolese, R.G. (1996). Ductal Carcinoma In Situ. In: Senn, H.J., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Breast Cancer V. Recent Results in Cancer Research, vol 140. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79278-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-79278-6_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79280-9
Online ISBN: 978-3-642-79278-6
eBook Packages: Springer Book Archive